Cataract

Study: Positive outcomes with dexamethasone intraocular suspension after cataract surgery

Early real-world data from numerous US centers demonstrate strong anti-inflammatory efficacy and safety of dexamethasone intraocular suspension 9% (DEXYCU, EyePoint Pharmaceuticals) comparable to controlled clinical trials, according to data reported at AAO 2020 Virtual. The researchers set out to characterize early real-world experiences with dexamethasone intraocular suspension 9% using data...